tiprankstipranks
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Income Statement

Compare
1,286 Followers

Summit Therapeutics Income Statement

Last quarter (Q3 2024), Summit Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Summit Therapeutics's net income was $-56.25M. See Summit Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 704.29K$ 1.81M$ 860.00K
Gross Profit
$ -15.01M$ -2.05M$ -1.81M$ 1.81M$ 860.00K
Operating Expenses
$ 211.30M$ 87.69M$ 64.28M$ 88.00M$ 53.19M
Depreciation and Amortization
$ 0.00$ 90.74M$ 2.51M$ 2.46M$ 2.00M
EBITDA
$ 313.00K$ 1.00M$ -52.63M$ -62.74M$ -37.13M
Operating Income
$ 313.00K$ -89.74M$ -72.09M$ -86.19M$ -53.19M
Other Income/Expenses
$ -221.63M$ -526.14M$ -19.15M$ -24.87M$ -14.01M
Pretax Income
$ -221.31M$ -615.87M$ -78.78M$ -88.60M$ -52.91M
Net Income
$ -221.31M$ -614.93M$ -74.38M$ -86.15M$ -52.70M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.31$ -0.99$ -0.38$ -0.93$ -0.76
Diluted EPS
$ -0.31$ -0.99$ -0.38$ -0.93$ -0.76
Weighted Average Shares Outstanding
718.54M 619.65M 193.34M 92.24M 69.52M
Weighted Average Shares Outstanding (Diluted)
718.54M 619.65M 193.34M 92.24M 69.52M
Currency in USD

Summit Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis